Acquired reactive perforating collagenosis and pseudoporphyric bullous dermatosis in a hemodialysis patient

被引:4
|
作者
Sabanis, Nikos [1 ]
Paschou, Eleni [2 ]
Gavriilaki, Eleni [3 ]
Kalaitzoglou, Asterios [3 ]
Papanikolaou, Dimitrios [4 ]
Vasileiou, Sotiris [1 ]
Amplianitis, Ioannis [5 ]
机构
[1] Gen Hosp Pella, Dept Nephrol, Edessa, Greece
[2] Gen Hosp Pella, Dept Gen Practice & Family Med, Edessa, Greece
[3] Aristotle Univ Thessaloniki, Med Sch, Thessaloniki, Greece
[4] Gen Hosp Pella, Dept Gen Surg, Edessa, Greece
[5] Gen Hosp Hippokrate, Dept Pathol, Thessaloniki, Greece
关键词
Hemodialysis; skin disorders; acquired reactive perforating collagenosis; pseudoporphyria cutanea tarda; ORAL N-ACETYLCYSTEINE; DIALYSIS; ALLOPURINOL; DISEASE;
D O I
10.1111/hdi.12402
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Hemodialysis patients present with a broad spectrum of specific and nonspecific skin disorders, which rarely coexist. We report an exceptional case of a hemodialysis patient that developed acquired reactive perforating collagenosis and pseudoporphyric bullous dermatosis on the basis of common skin disorders which include hyperpigmentation, pruritus, xerosis cutis, and Linsday's nails. Interestingly, our patient presented with two unusual but distinctive cutaneous dermopathies on the background of other commonly seen skin alterations. The patient was successfully treated with allopurinol and N-acetylcysteine. Avoidance of potentially triggering factors such as alcohol, sunlight exposure and certain medication was recommended. Thus, increasing clinical awareness, assiduous investigation and early treatment of skin disorders are required to improve the prognosis and quality of life in this patient population.
引用
收藏
页码:E14 / E18
页数:5
相关论文
共 50 条
  • [41] A new clinical variant of acquired reactive perforating dermatosis-like bullous pemphigoid
    Schauer, F.
    Kern, J. S.
    Virtic, O.
    Technau-Hafsi, K.
    Meiss, F.
    Thoma, K.
    Athanasiou, I.
    Sitaru, C.
    Di Zenzo, G.
    Izumi, K.
    Nishie, W.
    Shimizu, H.
    Bruckner-Tuderman, L.
    Kiritsi, D.
    BRITISH JOURNAL OF DERMATOLOGY, 2019, 180 (01) : 231 - 232
  • [42] Acquired perforating collagenosis in a non-diabetic patient with advanced prostate carcinoma: A review of perforating dermatosis associated with malignancy
    Kawahara, Saho
    Mitoma, Chikage
    Murai, Mika
    Furue, Masutaka
    JOURNAL OF DERMATOLOGY, 2018, 45 (08): : E219 - E220
  • [43] Acquired perforating collagenosis in a patient with carcinoma of the prostate
    Boeck, K
    Mempel, M
    Hein, R
    Ring, J
    ACTA DERMATO-VENEREOLOGICA, 1997, 77 (06) : 486 - 487
  • [44] A case of rheumatoid vasculitis with acquired reactive perforating collagenosis
    Ikeda, Takaharu
    Mikita, Naoya
    Furukawa, Fukumi
    Iwahashi, Yoshifumi
    MODERN RHEUMATOLOGY, 2019, 29 (03) : 547 - 550
  • [45] Acquired reactive perforating collagenosis triggered by scabies infection
    Kurschat, P
    Kröger, A
    Scharffetter-Kochanek, K
    Hunzelmann, N
    ACTA DERMATO-VENEREOLOGICA, 2000, 80 (05) : 384 - 385
  • [46] Successful treatment of acquired reactive perforating collagenosis with itraconazole
    Binrong Ye
    Yi Cao
    Yeqiang Liu
    European Journal of Medical Research, 26
  • [47] Type 2 diabetes and acquired reactive perforating collagenosis
    Patel, B.
    Kalathil, D.
    DIABETIC MEDICINE, 2018, 35 : 14 - 14
  • [48] Acquired Reactive Perforating Collagenosis: A Rare Association with Dermatomyositis
    Kikuchi, Nobuyuki
    Ohtsuka, Mikio
    Yamamoto, Toshiyuki
    ACTA DERMATO-VENEREOLOGICA, 2013, 93 (06) : 735 - 736
  • [49] Leucocytoclastic vasculitis associated with acquired reactive perforating collagenosis
    Mueller, Cornelia S. L.
    Tilgen, Wolfgang
    Rass, Knuth
    DERMATO-ENDOCRINOLOGY, 2009, 1 (04) : 229 - 231
  • [50] Successful treatment of acquired reactive perforating collagenosis with itraconazole
    Ye, Binrong
    Cao, Yi
    Liu, Yeqiang
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2021, 26 (01)